undefined cover
undefined cover
Automated image analysis : Biocellvia reads tissue to assess drug efficacy cover
Automated image analysis : Biocellvia reads tissue to assess drug efficacy cover
risingSUD Studio

Automated image analysis : Biocellvia reads tissue to assess drug efficacy

Automated image analysis : Biocellvia reads tissue to assess drug efficacy

12min |25/10/2019
Play
undefined cover
undefined cover
Automated image analysis : Biocellvia reads tissue to assess drug efficacy cover
Automated image analysis : Biocellvia reads tissue to assess drug efficacy cover
risingSUD Studio

Automated image analysis : Biocellvia reads tissue to assess drug efficacy

Automated image analysis : Biocellvia reads tissue to assess drug efficacy

12min |25/10/2019
Play

Description

In order to demonstrate the efficacy of candidate molecule, it is sometimes necessary to proceed to tissue analysis, based on some form of visual analysis.

Automated image analysis can provide a much more precise and much quicker way of achieving these histological analysis. Gaining time and precision in this process would be beneficial to both patients and the pharmaceutical industry. 

To talk about this topic today, we are hosting a startup using machine learning to improve biological image analysis

Biocellvia was created in 2011 in Marseilles and has already demonstrated the soundness of its solution in scientific papers. It is now scaling up the commercialization phase of its product

Biocellvia will be part of a Business Starter program in California organized for a delegation of companies based in region Sud. They will be in San Francisco and San Diego between November 11 and November 15, 2019.

If you want to know more about medtech in Région SUD, please visit the dedicated section of our website https://www.risingsud.fr/categories_ressource/therapies-innovantes/ 

If you want to know more about Biocellvia: www.biocellvia.com 

Linkedin profile of Olivier Julé, CEO at Biocellvia: https://www.linkedin.com/in/olivierjule/ 

Linkedin profile of Jean-Baptiste Geissler, Innovation Expert at risingSUD and host of the podcast series: https://www.linkedin.com/in/jean-baptiste-geissler-24323a13/ 

If you want to know more about risingSUD, please visit:

Our YouTube channel: https://www.youtube.com/channel/UC7fer3ND7A596b9S9CcdBvQ

Description

In order to demonstrate the efficacy of candidate molecule, it is sometimes necessary to proceed to tissue analysis, based on some form of visual analysis.

Automated image analysis can provide a much more precise and much quicker way of achieving these histological analysis. Gaining time and precision in this process would be beneficial to both patients and the pharmaceutical industry. 

To talk about this topic today, we are hosting a startup using machine learning to improve biological image analysis

Biocellvia was created in 2011 in Marseilles and has already demonstrated the soundness of its solution in scientific papers. It is now scaling up the commercialization phase of its product

Biocellvia will be part of a Business Starter program in California organized for a delegation of companies based in region Sud. They will be in San Francisco and San Diego between November 11 and November 15, 2019.

If you want to know more about medtech in Région SUD, please visit the dedicated section of our website https://www.risingsud.fr/categories_ressource/therapies-innovantes/ 

If you want to know more about Biocellvia: www.biocellvia.com 

Linkedin profile of Olivier Julé, CEO at Biocellvia: https://www.linkedin.com/in/olivierjule/ 

Linkedin profile of Jean-Baptiste Geissler, Innovation Expert at risingSUD and host of the podcast series: https://www.linkedin.com/in/jean-baptiste-geissler-24323a13/ 

If you want to know more about risingSUD, please visit:

Our YouTube channel: https://www.youtube.com/channel/UC7fer3ND7A596b9S9CcdBvQ

Share

Embed

You may also like

Description

In order to demonstrate the efficacy of candidate molecule, it is sometimes necessary to proceed to tissue analysis, based on some form of visual analysis.

Automated image analysis can provide a much more precise and much quicker way of achieving these histological analysis. Gaining time and precision in this process would be beneficial to both patients and the pharmaceutical industry. 

To talk about this topic today, we are hosting a startup using machine learning to improve biological image analysis

Biocellvia was created in 2011 in Marseilles and has already demonstrated the soundness of its solution in scientific papers. It is now scaling up the commercialization phase of its product

Biocellvia will be part of a Business Starter program in California organized for a delegation of companies based in region Sud. They will be in San Francisco and San Diego between November 11 and November 15, 2019.

If you want to know more about medtech in Région SUD, please visit the dedicated section of our website https://www.risingsud.fr/categories_ressource/therapies-innovantes/ 

If you want to know more about Biocellvia: www.biocellvia.com 

Linkedin profile of Olivier Julé, CEO at Biocellvia: https://www.linkedin.com/in/olivierjule/ 

Linkedin profile of Jean-Baptiste Geissler, Innovation Expert at risingSUD and host of the podcast series: https://www.linkedin.com/in/jean-baptiste-geissler-24323a13/ 

If you want to know more about risingSUD, please visit:

Our YouTube channel: https://www.youtube.com/channel/UC7fer3ND7A596b9S9CcdBvQ

Description

In order to demonstrate the efficacy of candidate molecule, it is sometimes necessary to proceed to tissue analysis, based on some form of visual analysis.

Automated image analysis can provide a much more precise and much quicker way of achieving these histological analysis. Gaining time and precision in this process would be beneficial to both patients and the pharmaceutical industry. 

To talk about this topic today, we are hosting a startup using machine learning to improve biological image analysis

Biocellvia was created in 2011 in Marseilles and has already demonstrated the soundness of its solution in scientific papers. It is now scaling up the commercialization phase of its product

Biocellvia will be part of a Business Starter program in California organized for a delegation of companies based in region Sud. They will be in San Francisco and San Diego between November 11 and November 15, 2019.

If you want to know more about medtech in Région SUD, please visit the dedicated section of our website https://www.risingsud.fr/categories_ressource/therapies-innovantes/ 

If you want to know more about Biocellvia: www.biocellvia.com 

Linkedin profile of Olivier Julé, CEO at Biocellvia: https://www.linkedin.com/in/olivierjule/ 

Linkedin profile of Jean-Baptiste Geissler, Innovation Expert at risingSUD and host of the podcast series: https://www.linkedin.com/in/jean-baptiste-geissler-24323a13/ 

If you want to know more about risingSUD, please visit:

Our YouTube channel: https://www.youtube.com/channel/UC7fer3ND7A596b9S9CcdBvQ

Share

Embed

You may also like